PrecivityAD2™ Blood Test Enhances Clinical Decision-Making: Study
February 1, 2025
Researchers have determined that healthcare providers increased their ability to make Alzheimer’s disease (AD) probability judgments on their patients when they used the PrecivityAD2™ blood biomarker